Achieve Life Sciences Inc
ACHV4.464USD
-0.276-5.82%
交易中 （美東）報價延遲15分鐘
221.79M總市值
虧損本益比TTM
關於 Achieve Life Sciences Inc 公司
Achieve Life Sciences, Inc. 是一家後期臨牀製藥公司。該公司致力於開發和商業化用於戒菸和尼古丁成癮的西替西尼克林。該公司的候選產品西替西尼克林是一種天然存在的植物性生物鹼。西替西尼克林的結構與尼古丁相似，具有明確的雙重作用機制，既有激動作用又有拮抗作用。西替西尼克林是一種部分激動劑，可與大腦中的 α-4 β-2 菸鹼乙酰膽鹼受體高親和力結合。通過其雙重作用的部分激動劑/部分拮抗劑活性，西替西尼克林有助於減少對尼古丁的渴望、戒斷症狀以及與吸菸相關的獎勵和滿足感。該公司正在開發西替西尼克林作爲戒菸和尼古丁成癮治療的輔助手段，以解決處方藥和非處方 (OTC) 產品的侷限性。
Achieve Life Sciences Inc簡介
公司代碼ACHV
公司名稱Achieve Life Sciences Inc
上市日期Oct 12, 1995
CEOMr. Richard Stewart
員工數量25
證券類型Ordinary Share
年結日Oct 12
公司地址22722 29Th Dr. Se
城市SEATTLE
上市交易所NASDAQ Capital Market Consolidated
國家United States of America
郵編98021
電話14256861500
網址https://achievelifesciences.com/
公司代碼ACHV
上市日期Oct 12, 1995
CEOMr. Richard Stewart
Achieve Life Sciences Inc公司高管
名稱
名稱/職務
職務
持股
持股變動
Mr. Mark K. Oki
Mr. Mark K. Oki
Chief Financial and Principal Financial Officer
Chief Financial and Principal Financial Officer
127.94K
+1179.40%
Ms. Jaime Xinos
Ms. Jaime Xinos
Chief Commercial Officer
Chief Commercial Officer
74.44K
+183.11%
Mr. Thomas B. King
Mr. Thomas B. King
Interim Executive Chairman of the Board
Interim Executive Chairman of the Board
--
--
Mr. Richard Stewart
Mr. Richard Stewart
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Ms. Nancy R. Phelan
Ms. Nancy R. Phelan
Independent Director
Independent Director
--
--
Dr. Kristen B. Slaoui, Ph.D.
Dr. Kristen B. Slaoui, Ph.D.
Independent Director
Independent Director
--
--
Mr. Stuart Duty
Mr. Stuart Duty
Independent Director
Independent Director
--
--
Dr. Bridget A. Martell, M.D.
Dr. Bridget A. Martell, M.D.
Independent Director
Independent Director
--
--
Mr. Thomas Sellig
Mr. Thomas Sellig
Independent Director
Independent Director
--
--
Ms. Nicole Jones
Ms. Nicole Jones
Investor Relations
Investor Relations
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Mark K. Oki
Mr. Mark K. Oki
Chief Financial and Principal Financial Officer
Chief Financial and Principal Financial Officer
127.94K
+1179.40%
Ms. Jaime Xinos
Ms. Jaime Xinos
Chief Commercial Officer
Chief Commercial Officer
74.44K
+183.11%
Mr. Thomas B. King
Mr. Thomas B. King
Interim Executive Chairman of the Board
Interim Executive Chairman of the Board
--
--
Mr. Richard Stewart
Mr. Richard Stewart
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Ms. Nancy R. Phelan
Ms. Nancy R. Phelan
Independent Director
Independent Director
--
--
Dr. Kristen B. Slaoui, Ph.D.
Dr. Kristen B. Slaoui, Ph.D.
Independent Director
Independent Director
--
--
收入明細
暫無數據
暫無數據
業務
地區
暫無數據
股東統計
更新時間: 9月10日 週三
更新時間: 9月10日 週三
持股股東
股東類型
持股股東
持股股東
佔比
Propel Bio Management, LLC
19.28%
Franklin Advisers, Inc.
8.73%
Alyeska Investment Group, L.P.
6.86%
The Vanguard Group, Inc.
4.21%
Contrarian Alpha Management, L.L.C.
3.02%
其他
57.91%
持股股東
持股股東
佔比
Propel Bio Management, LLC
19.28%
Franklin Advisers, Inc.
8.73%
Alyeska Investment Group, L.P.
6.86%
The Vanguard Group, Inc.
4.21%
Contrarian Alpha Management, L.L.C.
3.02%
其他
57.91%
股東類型
持股股東
佔比
Venture Capital
19.28%
Hedge Fund
15.74%
Investment Advisor
13.95%
Investment Advisor/Hedge Fund
11.32%
Individual Investor
5.15%
Research Firm
1.09%
Bank and Trust
0.01%
其他
33.45%
機構持股
更新時間: 10月1日 週三
更新時間: 10月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2025Q3
148
31.38M
61.40%
+12.18M
2025Q2
148
20.35M
40.95%
+719.94K
2025Q1
153
17.96M
40.70%
-1.67M
2024Q4
146
23.37M
67.97%
-345.80K
2024Q3
139
24.25M
71.81%
-1.59M
2024Q2
126
25.87M
76.52%
+2.27M
2024Q1
101
23.59M
82.23%
+11.64M
2023Q4
89
9.84M
47.28%
+1.08K
2023Q3
88
8.70M
44.68%
-1.20M
2023Q2
86
9.15M
47.00%
+473.03K
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Propel Bio Management, LLC
9.85M
19.28%
+7.40M
+301.66%
Jun 30, 2025
Franklin Advisers, Inc.
4.46M
8.73%
+2.00M
+81.34%
Jun 30, 2025
Alyeska Investment Group, L.P.
3.50M
6.86%
+3.08M
+732.38%
Jun 30, 2025
The Vanguard Group, Inc.
2.15M
4.21%
+432.86K
+25.21%
Jun 30, 2025
Contrarian Alpha Management, L.L.C.
1.54M
3.02%
+105.00K
+7.30%
May 15, 2024
Patrick (Callahan J. III)
1.53M
2.99%
--
--
Apr 15, 2025
Clearline Capital LP
1.33M
2.6%
+1.33M
--
Jun 30, 2025
Simplify Asset Management Inc
1.18M
2.32%
+966.67K
+443.74%
Jun 30, 2025
Hudson Bay Capital Management LP
1.17M
2.3%
+1.17M
--
Jun 30, 2025
Heights Capital Management, Inc.
989.51K
1.94%
+989.51K
--
Jun 30, 2025
查看更多
持股ETF
更新時間: 11月6日 週四
更新時間: 11月6日 週四
機構名稱
佔比
Simplify Propel Opportunities ETF
5.64%
iShares Micro-Cap ETF
0.02%
iShares Russell 2000 Value ETF
0%
iShares Russell 2000 Growth ETF
0%
Global X Russell 2000 ETF
0%
ProShares UltraPro Russell2000
0%
Proshares Ultra Russell 2000
0%
ProShares Hedge Replication ETF
0%
iShares Russell 2000 ETF
0%
Simplify Propel Opportunities ETF
佔比5.64%
iShares Micro-Cap ETF
佔比0.02%
iShares Russell 2000 Value ETF
佔比0%
iShares Russell 2000 Growth ETF
佔比0%
Global X Russell 2000 ETF
佔比0%
ProShares UltraPro Russell2000
佔比0%
Proshares Ultra Russell 2000
佔比0%
ProShares Hedge Replication ETF
佔比0%
iShares Russell 2000 ETF
佔比0%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
Jul 30, 2020
Merger
20→1
Jul 30, 2020
Merger
20→1
Jul 30, 2020
Merger
20→1
Jul 30, 2020
Merger
20→1
公告日期
類型
比率
Jul 30, 2020
Merger
20→1
Jul 30, 2020
Merger
20→1
Jul 30, 2020
Merger
20→1
Jul 30, 2020
Merger
20→1
